Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor–based orthotopic xenograft mouse models of pediatric glioma

Ítems similars

• A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models
  per: Yu, Litian, et al.
  Publicat: (2011)
• MB-30 ONCOLYTIC PICORNAVIRUS SVV-001 PROLONGS ANIMAL SURVIVAL IN A PATIENT TUMOR-DERIVED ORTHOTOPIC XENOGRAFT MOUSE MODEL OF GROUP 3 SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR
  per: Liu, Zhigang, et al.
  Publicat: (2015)
• Structure of Seneca Valley Virus-001, An oncolytic picornavirus representing a new genus
  per: Venkataraman, Sangita, et al.
  Publicat: (2008)
• Phase I Clinical Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features
  per: Rudin, Charles M., et al.
  Publicat: (2011)
• Crystallization and preliminary X-ray diffraction studies of Seneca Valley Virus-001, a new member of the Picornaviridae family
  per: Venkataraman, Sangita, et al.
  Publicat: (2008)